Doug Carey

517 total citations
11 papers, 470 citations indexed

About

Doug Carey is a scholar working on Molecular Biology, Pharmacology and Pathology and Forensic Medicine. According to data from OpenAlex, Doug Carey has authored 11 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Doug Carey's work include Drug-Induced Hepatotoxicity and Protection (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Free Radicals and Antioxidants (2 papers). Doug Carey is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (3 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Free Radicals and Antioxidants (2 papers). Doug Carey collaborates with scholars based in Canada. Doug Carey's co-authors include Donald A.G. Mickle, Jun Wu, Tai-Wing Wu, Ren‐Ke Li, Noriaki Hashimoto, Jun Wu, Jun Wu, Hiroshi Sugiyama, Richard D. Weisel and Ling-Hua Zeng and has published in prestigious journals such as Hepatology, Life Sciences and Biochemistry and Cell Biology.

In The Last Decade

Doug Carey

11 papers receiving 459 citations

Peers

Doug Carey

MB

PPCH

PFM

PHYSI

OC

Charita Seneviratne Canada

Akihiro Fujioka Japan

Z. Zaman Belgium

Stefanie Oberle Germany

Shuzo Moritani Japan

Kiyokazu Hagiwara Japan

Ümit Mutlu-Türkoğlu Türkiye

Teri A. Frosto United States

E Marcinkiewicz Poland

Irène Zbinden Switzerland

Charita Seneviratne Canada

Doug Carey

386 ×1.6

MB

42 ×0.5

PPCH

80 ×1.0

PFM

122 ×2.2

PHYSI

38 ×0.7

OC

Citations per year, relative to Doug Carey Doug Carey (= 1×) peers Charita Seneviratne

Countries citing papers authored by Doug Carey

Since Specialization

Citations

This map shows the geographic impact of Doug Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doug Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doug Carey more than expected).

Fields of papers citing papers by Doug Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doug Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doug Carey. The network helps show where Doug Carey may publish in the future.

Co-authorship network of co-authors of Doug Carey

This figure shows the co-authorship network connecting the top 25 collaborators of Doug Carey. A scholar is included among the top collaborators of Doug Carey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doug Carey. Doug Carey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Wu, Tai-Wing, et al.. (1994). Purpurogallin: In vivo evidence of a novel and effective cardioprotector. Life Sciences. 54(2). PL23–PL28. 13 indexed citations

2.

Wu, Jun, et al.. (1993). Radiochemical quantitation of conjugated dienes in rat hepatocytes exposed to oxyradicals. Life Sciences. 53(10). 833–837. 4 indexed citations

3.

Wu, Tai-Wing, Zdenek B. Pristupa, Ling-Hua Zeng, et al.. (1992). Enhancement in antioxidant-based hepatoprotective activity of trolox by its conjugation to lactosylphenylpyranoside. Hepatology. 15(3). 454–458. 11 indexed citations

4.

Wu, Jun, et al.. (1992). Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage. Biochemistry and Cell Biology. 70(9). 803–809. 19 indexed citations

5.

Carey, Doug, et al.. (1991). The cytoprotective effects of bilirubin and biliverdin on rat hepatocytes and human erythrocytes and the impact of albumin. Biochemistry and Cell Biology. 69(12). 828–834. 52 indexed citations

6.

Wu, Jun, et al.. (1991). Trolox and ascorbate: are they synergistic in protecting liver cells in vitro and in vivo?. Biochemistry and Cell Biology. 69(2-3). 198–201. 25 indexed citations

7.

Wu, Jun, et al.. (1991). Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochemistry and Cell Biology. 69(10-11). 683–688. 107 indexed citations

8.

Carey, Doug, et al.. (1991). Validation of the morphologic end point of necrosis in rat hepatocytes subjected to oxyradical damage. Biochemistry and Cell Biology. 69(10-11). 689–694. 12 indexed citations

9.

Zeng, Ling-Hua, et al.. (1991). Purpurogallin—a natural and effective hepatoprotector in vitro and in vivo. Biochemistry and Cell Biology. 69(10-11). 747–750. 23 indexed citations

10.

Wu, Tai-Wing, et al.. (1991). Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology. 13(3). 575–580. 95 indexed citations

11.

Wu, Tai-Wing, Noriaki Hashimoto, Jun Wu, et al.. (1990). The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochemistry and Cell Biology. 68(10). 1189–1194. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact